Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
Altor Bioscience Corporation Identifier:
First received: September 20, 2011
Last updated: September 21, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):